Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120986036 | 12098603 | 6 | F | 2008 | 20160912 | 20160222 | 20160921 | EXP | CA-AMGEN-CANSP2016019575 | AMGEN | 53.00 | YR | A | F | Y | 0.00000 | 20160921 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120986036 | 12098603 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, WEEKLY | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 120986036 | 12098603 | 2 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 120986036 | 12098603 | 3 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 400 MG, QD | 0 | 400 | MG | TABLET | QD | ||||||
| 120986036 | 12098603 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 120986036 | 12098603 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 25 MG, QWK | 0 | 25 | MG | /wk | |||||||
| 120986036 | 12098603 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 120986036 | 12098603 | 7 | C | NAPROSYN | NAPROXEN | 1 | 500 MG, AS NECESSARY | 0 | 500 | MG | |||||||||
| 120986036 | 12098603 | 8 | C | LOSEC | OMEPRAZOLE | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 120986036 | 12098603 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 20 MG, QD | 0 | 20 | MG | TABLET | QD | |||||||
| 120986036 | 12098603 | 10 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120986036 | 12098603 | 1 | Rheumatoid arthritis |
| 120986036 | 12098603 | 2 | Product used for unknown indication |
| 120986036 | 12098603 | 3 | Rheumatoid arthritis |
| 120986036 | 12098603 | 4 | Rheumatoid arthritis |
| 120986036 | 12098603 | 10 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120986036 | 12098603 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120986036 | 12098603 | Condition aggravated | |
| 120986036 | 12098603 | Drug ineffective | |
| 120986036 | 12098603 | Herpes zoster | |
| 120986036 | 12098603 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120986036 | 12098603 | 2 | 2010 | 2011 | 0 | |
| 120986036 | 12098603 | 3 | 2008 | 2016 | 0 | |
| 120986036 | 12098603 | 4 | 2008 | 0 | ||
| 120986036 | 12098603 | 10 | 20160426 | 0 |